MAPT and Alzheimer disease: The ERlangen Score combines the two neuropathological hallmarks of AD, amyloid pathology and tau pathology, in an ordinal score that allows the risk of dementia to be assessed independently of the laboratory and does not, like the pTau/Aβ1-42, assume that the biological processes of amyloid and tau deposits are in a linear relationship with each other [13,25].